2026. Designed Tripeptides as Potent NPM1 Oligomerization Inhibitors: A Molecular Docking and Dynamics Study Toward New Anticancer Drug Candidates. International Journal of Environmental Sciences. (Jan. 2026), 537–547. DOI:https://doi.org/10.64252/ckvg7k02.